---
title: CV
format:
  quarto-cv-pdf: default
author: Alexandros Rekkas
date: last-modified
phone: "{{< env PHONE >}}"
address: "{{< env ADDRESS >}}"
email: "{{< env EMAIL >}}"
fontsize: 11pt
fontfamily: quattrocento
github: rekkasa
orcid: 0000-0002-5352-943X
#osf: ymqui # osf five character id
#twitter: twitter # twitter handle
# web: quarto.org
fontawesome: yes
nocite: '@*'
bibliography: 
  peer: peer_bib.bib
validate-yaml: false
csl: apa-numeric.csl
---

# Personal data

\begin{tabular}{ l l l }
\textit{Name:} Alexandros & \textit{Father's Name:} Konstantinos & \textit{Date of Birth:} September 30th, 1991 \\
\textit{Surname:} Rekkas & \textit{Mother's Name:} Eugenia & \textit{Place of Birth:} Thessaloniki, Greece \\
\end{tabular}

# Education

*Erasmus Medical Center* \hfill Rotterdam, Netherlands \newline
Ph.D. Medical Informatics \hfill 2017-2023

> *Thesis*: [Beyond the average treatment effect: Risk-based approaches to medical
> decision making](https://pure.eur.nl/files/103693281/beyond-the-average-treatment-effect_-_652e948913b3f.pdf)

> *Supervisors*: Prof. P.R. Rijnbeek, Prof. E.W. Steyerberg, Dr. D. van Klaveren


*KU Leuven* \hfill Leuven, Belgium \newline
M.Sc. Statistics (cum laude) \hfill 2015-2017

> *Thesis*: Robust model selection for generalized linear models

> *Supervisor*: Prof. S. Van Aelst

*Aristotle University of Thessaloniki* \hfill Thessaloniki, Greece \newline
B.Sc. Mathematics \hfill 2009-2015

# Projects

*Risk stratified estimtation*

> Developed and maintained the R-package *RiskStratifiedEstimation* used for carrying out risk-stratified evaluation of
> treatment effect heterogeneity in observational databases mapped to OMOP-CDM. Visit the project at
> [github](https://github.com/ohdsi/RiskStratifiedEstimation). The package won the 2020 Best Contribution in Open-Source
> Analytics Development at the 2020 OHDSI Global Symposium
> [[link](https://www.ohdsi.org/2020-global-symposium-collaborator-showcase/)].

*Covid outcome prediction in the Emergency Department*

> Developed an online calculator in the form of a Shiny application for the
> [COPE prediction model](https://doi.org/10.1136/bmjopen-2021-051468). The calculator provided death and ICU admission
> risks within 28 days of hospital admission. Visit the project at [github](https://github.com/mi-erasmusmc/COPE).

*Patient-level prediction*

> Contributed to the development of the R-package *PatientLevelPrediction*, part of the
> [HADES](https://ohdsi.github.io/Hades) suite of software. The package is used extensively for carrying out prediction
> tasks on observational databases mapped to OMOP-CDM. Visit the project at
> [github](https://github.com/OHDSI/PatientLevelPrediction).

*EHDEN MegaStudy*

> As member of the Greek National Node of OHDSI, was responsible for executing the code of the EHDEN Network study on
> drug shortages on the database of the Papageorgiou General Hospital of Thessaloniki, Greece and sharing the results
> with collaborators. The database is mapped to OMOP-CDM.

# Internship

*P-95 Pharmacoepidemiology* \hfill 6-7/2016

> *Supervisor*: Dr. Kaatje Bollaerts

> *Description*: Assisted in the derivation of analytical expressions for all validity indices used to evaluate
> case-finding algorithms in observational databases. The aim was to derive all validity indices and the true prevalence
> of disease from observed prevalence and any two other parameters.


# Skills

> *Programming*: R, Python

> *Languages*: Greek (native speaker), English (C2), German (B2)

# Research programmes

1. [European Health Data and Evidence Network](https://www.ehden.eu/) (EHDEN project), 2018-2024. Participated from
   December 1st, 2019 till November 30th, 2023.

2. [Accelarated Development of Vaccine Benefit-risk Collaboration in
   Europe](https://www.imi.europa.eu/projects-results/project-factsheets/advance) (ADVANCE project), 2013-2019.
   Participation June 1st till July 31st, 2016.


# Teaching

1. Teaching assistance for the course "Advanced Analysis of Prognosis Studies", Winter-Spring 2018-2019, Netherlands
   Institute for Health Sciences, Erasmus MC, Rotterdam.

2. Tutorial with title "Population-Level Estimation" at the 2019 OHDSI Symposium, North Bethesda, USA, September 19th,
   2019

3. Supervised the three-month internship of master student Gidius van de Kamp in 2023. The internship aimed at
   developing a R-package for performing plasmode simulations using data mapped to the OMOP common data model. This
   resulted in poster presentation 12 below.

4. Invited speaker at the 2024 Summer School of the M.Sc. programme in Biomedical Engineering of the Aristotle
   University of Thessaloniki. Title of the course was "Machine learning applications using OMOP-CDM"

5. Tutor at the 2024 Training School on "Impact of Meta-analyses on Clinical Practice" organised by The European Network
   on Osteoarthritis.

# Publications

::: {#refs-peer}
:::

# Conferences and symposia

1. *Poster presentation*: Risk Stratified Analysis of Treatment Effect in
Electronic Health Records. **Alexandros Rekkas**, Peter R. Rijnbeek, Jenna Reps,
David Van Klaveren. First Annual European OHDSI Symposium, Rotterdam, The
Netherlands, March 23rd, 2018 [[link](https://www.ohdsi-europe.org/images/symposium-2018/posters/31-Alexandros-Rekkas.pdf)]

2. *Poster presentation*: Exploring Heterogeneity of Treatment Effects:
Develompent of a New OHDSI Analytics Package and Demonstration Using the
Gastrointestinal Bleeding Risk of Celecoxib. **Alexandros Rekkas**, Peter R.
Rijnbeek, James Weaver, Martijn Schuemie, Jenna Reps, David Van Klaveren. 2018
OHDSI Symposium, North Bethesda, USA, October 12th, 2018 [[link](https://www.ohdsi.org/wp-content/uploads/2018/10/2018-Poster-Session-FINAL-200-black-and-white-copies-double-sided-stapled.pdf)]

3. *Poster presentation*: Development of a R-package to Explore Heterogeneity of
Treatment Effects: A Demonstration in Patients with Hypertension. **Alexandros
Rekkas**, David van Klaveren, Peter R. Rijnbeek. Second Annual European OHDSI
Symposium, Rotterdam, The Netherlands, March 29th, 2019 [[link](https://www.ohdsi-europe.org/images/symposium-2019/posters/24_Alexandros_Rekkas.pdf)]

4. *Poster presenation*: Assessing Heterogeneity of Hypertension Treatment
Effects: A Risk Modeling Approach. **Alexandros Rekkas**, David van Klaveren,
Peter R. Rijnbeek. 2019 OHDSI Symposium, North Bethesda, USA, September 16th,
2019 [[link](https://www.ohdsi.org/2019-us-symposium-showcase-39/)]

5. *Poster presentation*: Large-scale evaluation of treatment effect
heterogeneity in hypertension. **Alexandros Rekkas**, David van Klaveren, Peter
R. Rijnbeek. 2020 OHDSI Global Symposium, Online Symposium, October 19th, 2020 
[[link](https://www.ohdsi.org/2020-global-symposium-showcase-63/)].

6. *Poster presentation*: Treatment heterogeneity in comparative effectiveness
of teriparatide vs bisphosphonates: multi-database cohort study, **Alexandros
Rekkas**, Annika M. Jodicke, David van Klaveren, Daniel Prieto-Alhambra, Peter
R. Rijnbeek. 2021 OHDSI Global Symposium, Online Symposium, September 14th, 2021
[[link](https://www.ohdsi.org/2021-global-symposium-showcase-95/)]

7. *Poster presentation*: Trends in the development and validation of
patient-level prediction models using electronic health record data: a
systematic review, Cynthia Yang, Jan A. Kors, Solomon Ioannou, Luis H. John,
Aniek F. Markus, **Alexandros Rekkas**, Maria de Ridder, Tom Seinen, Ross D.
Williams, Peter R. Rijnbeek. 2021 OHDSI Global Symposium, Online Symposium,
September 14th, 2021 [[link](https://www.ohdsi.org/2021-global-symposium-showcase-55/)]

8. *Oral presentation*: Assessing treatment effect heterogeneity using the
RiskStratifiedEstimation R-package, **Alexandros Rekkas**, David van Klaveren,
Peter R. Rijnbeek, Third European OHDSI Symposium, Rotterdam, The Netherlands,
June 24th, 2022 [[link](https://www.ohdsi-europe.org/images/symposium-2022/posters/arekkas_poster_-_Alexandros_Rekkas.pdf)]
[[video](https://www.youtube.com/watch?v=wYgk-qn-teo)]

9. *Oral presentation*: Predicting individualized treatment effects using
baseline risk: A simulation study, **Alexandros Rekkas**, Peter R. Rijnbeek,
David M. Kent, Ewout W. Steyerberg, David van Klaveren. 43rd Annual Conference
of the International Society of Biostatistics, Newcastle, UK, August 21-25, 2022 \
Pages 31 and 94 in the book of abstracts
([link](https://iscb.international/wp-content/uploads/2022/08/ISCB_2022-PROGRAMME-final.pdf)).

10. *Oral presentation*: Treatment heterogeneity in comparative effectiveness
ofTeriparatide versus Bisphosphonates: Multi-database cohort study, **Alexandros
Rekkas**, Annika Joedicke, David van Klaveren, Daniel Prieto-Alhambra, Peter R.
Rijnbeek. 38th International Conference on Pharmacoepidemiology, Copenhagen,
Denmark, August 26-28, 2022. \
Page 57 in the ICPE 2022 Final Program ([link](https://pharmacoepi.org/pub/?id=A15839AD-B6E4-D28E-1C20-FA5A5B1D2B50))

11. *Poster presentation*: A standardized framework for risk-based assessment of
treatment effect heterogeneity in observational healthcare databases,
**Alexandros Rekkas**, David van Klaveren, Patrick B. Ryan, Ewout W. Steyerberg,
David M. Kent, Peter R. Rijnbeek. SMDM 18th Biennial European Conference,
Berlin, Germany, May 21-23, 2023. \
Poster session 2 ([link](https://www.smdmmeeting.org/meeting-program/program-overview/))

12. *Poster presentation*: PlasmodeSim: R package to simulate data with known
treatment assignment and outcome generating processes, Gidius van de Kamp,
**Alexandros Rekkas** , Fourth European OHDSI Symposium, Rotterdam, The
Netherlands, July 3rd, 2023 [[link](https://www.ohdsi-europe.org/images/symposium-2023/posters/plasmode_simulation_gvk_ar_-_Alexandros_Rekkas.pdf)]

13. *Oral presentation*: Evaluation of treatment effect heterogeneity in the
LEGEND-Hypertension study, **Alexandros Rekkas**, David van Klaveren, Jenna M.
Reps, Peter R. Rijnbeek, Fourth European OHDSI Symposium, Rotterdam, The
Netherlands, July 3rd, 2023 [[link](https://www.ohdsi-europe.org/images/symposium-2023/posters/rekkas_legend_htn_hte_poster_-_Alexandros_Rekkas.pdf)] [[video](https://www.youtube.com/watch?v=wgiIHdf5P4Y)]
